Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-23-000004

Options or other derivatives

  • Director acquired 79,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Clark Kenneth A · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-03 Grant or award : show line 1 in the form Stock Option (right to buy) +35,000 35,000 D
2023-01-03 Grant or award : show line 2 in the form Stock Option (right to buy) +44,400 $1.67 $74,148 79,400 D
Loading xslF345X03/wf-form4_167295314354996.xml…